Tilpisertib FosmecarbilStudy of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor:

Gilead Sciences

Code:

NCT06029972

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tilpisertib Fosmecarbil

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2026-02-11.